Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-19 · accession 0001946439-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-23 | 2026-02-19+ | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $77.74 | -3,814 | 51.0K | -7% | -$296.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | S | D | 1,730 | $77.99 | 49,263 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $77.45 to $78.58. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2026-02-19 | S | D | 2,084 | $77.53 | 50,993 | D | — | — |